This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit January 14, 2015


 

Advertisement

Scientists identify new gene that drives triple-negative breast cancer
Medical News Today
In a new study, researchers from the U.K. have discovered a novel gene that, when mutated, can drive development and progression of triple-negative breast cancer — an aggressive form of the disease that accounts for 10 percent to 20 percent of breast cancers.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


A first in lung cancer: Immunotherapy improves survival
Medscape
The immune checkpoint inhibitor nivolumab (Opvido, Bristol-Myers Squibb), which was recently approved for use in melanoma, has shown a survival advantage over chemotherapy in a pivotal trial in lung cancer. The trial (known as CheckMate 017) was stopped early due to benefit. This is the first time that a survival advantage has been demonstrated in lung cancer with an immunomodulator drug, the company notes. It announced the top-line result of a superior overall survival in a press release and says that clinical data will be presented at a forthcoming meeting.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


End of cancer genome project prompts rethink of research strategy
Scientific American
A mammoth U.S. effort to genetically profile 10,000 tumors has officially come to an end. Started in 2006 as a U.S. $100 million pilot, The Cancer Genome Atlas is now the biggest component of the International Cancer Genome Consortium, a collaboration of scientists from 16 nations that has discovered nearly 10 million cancer-related mutations. The question is what to do next.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Daniel McKellar, MD, FACS, CoC chair, speaking at the SSO Pre-Meeting
The Society of Surgical Oncology (SSO) is offering a half-day Pre-Meeting "Update Course in Surgical Oncology for the Practicing Surgeon" from 1-6 p.m on Wednesday, March 25 in Houston at the Hilton Americas-Houston Hotel. This session brings together a number of the most influential thought leaders in surgical oncology speaking about controversies, changing standards of care, and practical information for the management of common malignancies and more. CoC Chair Daniel McKellar, MD,FACS, will address "How the Commission on Cancer Serves the Needs of Surgical Oncologists and Patients with Cancer." In addition the following individuals will be sharing their expertise: Armando Guiliano, MD (axilla), Monica Morrow, MD (breast cancer margins), Barbara Lynn Smith, MD, PhD, (nipple-sparing mastectomy), Merrick Ross, MD, (melanoma), Ashok Shaha, MD (thyroid cancer), Kelly Hunt, MD, (clinical trials), José G. Guillem, MD, MPH (colorectal cancer), and Harald Hoekstra, MD, PhD (Global issues. Time will be available for questions and discussions. Save the date now, and plan to arrive a day early in Houston to attend this special course. For further information visit the SSO 2015 schedule.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  Automate Patient Engagement. Improve Outcomes.

Our eBook, “Automate Patient Engagement. Improve Outcomes. NextGen Population Health,” is the perfect guide to help you see how an integrated population health solution can help you automate the patient engagement process, better achieve value-based outcomes – all while seeing a significant ROI in 10 easy steps. Download now.
 


Studies reaffirm that healthy behaviors can cut cancer risk
Medscape
As people make their resolutions for 2015, two new studies — which show that curbing alcohol consumption, adding more plant foods to the diet, and losing excess weight can help reduce the risk of developing cancer — serve as a reminder that a healthy lifestyle is important. The first study, published online Jan. 6 in Cancer Causes & Control, showed that eating a plant-based diet and limiting alcohol intake, both already included in various cancer prevention guidelines, could help cut the risk for obesity-related cancers (about a third of all of cancers).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of The Brief? Click here to visit The Brief archive page.


NCDB to accept PUF Applications January 2015
ACS
The National Cancer Data Base (NCDB) is pleased to announce it will now be accepting applications on a semi-annual basis. From Jan. 5-31, the NCDB will accept applications for organ-site specific files including cases diagnosed between 1998 and 2012. In July 2015, the NCDB will begin accepting applications for organ-site specific files including cases diagnosed between 1998 and 2013.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


Key features of the CMMI oncology care model
OncLive
To date, enthusiasm for bundled pricing has been associated with the Medicare Bundled Payments for Care Improvement initiative, which has consisted principally of cardiac and orthopaedic procedures with a hospital inpatient component. But what about modifying the payment methods for oncology/cancer care? Is oncology next in line for alternate/bundled payment?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Preparing for January's NCDB Call for Data: Pre-edit now
ACS
The annual National Cancer Data Base (NCDB) Call for Data opened Jan. 1. Submissions received after midnight CT Jan. 31 will be considered "late" for Standard 5.5. Under very unusual circumstances, the CoC grants short extensions. Please email Kathleen Thoburn at kthoburn@facs.org for extension requests, identifying the reason for the request, how long you expect the problem to last, and the Facility Identification Number (FIN) for the program requesting the extension. Thoburn will inform you of whether the extension has been granted and for how long.

The edits are ready for pre-editing data for submissions to NCDB and the Rapid Quality Reporting System (RQRS) in 2015. For registries whose software is using layout 14, information needed for editing is posted. For registries that will upgrade to layout 15 before submission, equivalent information will be available when the conversion program is made available to software providers.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  Casefinding, Abstracting and Follow-up
We provide accurate oncology data collection with a team of experienced and credentialed consultants. For the highest oncology data quality standards, work with the team at Care Communications, Inc.

Learn more about Oncology Data Services.

Download our white paper: “Making Sense of the Rapid Quality Reporting System.”
 


Merck, Bristol heat up immunotherapy race in lung cancer
Reuters
Bristol-Myers Squibb and Merck & Co broke further away from rival drugmakers in the race to treat lung cancer with a new generation of immune system therapies, adding pressure on the likes of Roche and AstraZeneca to play catch-up.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Registration now open for Accreditation 101: Learning the Basics of CoC Accreditation and Standards
ACS
The Commission on Cancer (CoC), a Quality Program of the American College of Surgeons, encourages you to attend Accreditation 101: Learning the Basics of CoC Accreditation and Standards in Chicago on February 27, 2015. This program provides practical information on how to achieve compliance and discusses your role as a member of a patient-centered, multidisciplinary cancer care team. This is the only education program that is developed and taught by CoC surveyors and staff. Learn how to turn theory into reality and see how the CoC standards can be used as a guide for the development of a high-quality program that treats patients with cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Blood test for prostate cancer investigated
Vanderbilt University Medical Center via ScienceDaily
A method for detecting "cell-free" tumor DNA in the bloodstream has been developed by scientists who believe that the technique will be transformative in providing improved cancer diagnostics that can both predict treatment outcomes and monitor patient responses to therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Call for research into needs of cancer survivors
Cancer Research UK
Around one in three U.S. cancer survivors have unmet physical, psychological and social needs decades after their treatment finished, according to new research. As more people are diagnosed with cancer across the Western world, experts said the results highlight the need for further focus on understanding the needs of cancer survivors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    MRI improves breast cancer screening in older BRCA carriers (Cancer Network)
Suspicious breast mass may pose greater risk than previously thought (Reuters)
Cancer vaccine ImMucin shows promising results after clinical trial; may work on 90 percent of all cancer types (Medical Daily)
Cancer prevention guidelines may lower risk of obesity-linked cancers (Medical Xpress)
NCDB to accept PUF Applications January 2015 (ACS)

Don't be left behind. Click here to see what else you missed.
 
Advertisement



The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Jan. 7, 2015
Dec. 30, 2014
Dec. 23, 2014
Dec. 10, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063